Скачать с ютуб Atacicept; A Novel Inhibitor of BAFF and APRIL In Development for the Treatment of IgAN в хорошем качестве

Atacicept; A Novel Inhibitor of BAFF and APRIL In Development for the Treatment of IgAN

This lunch talk at GlomCon Hawaii 2024 is sponsored by Vera Therapeutics Speakers: Dr. Kerry Cooper, SVP Medical Affairs Vera Therapeutics Dr. Richard Lafayette, Professor of Medicine and Director, Stanford Glomerular Disease Center -------- Introducing GlomCon Hawaii 2024 GlomCon Hawaii 2024 launches an exciting new chapter in our learning experience: a hybrid event that combines a Satellite Symposium with core conference sessions, all hosted in Maui at the idyllic Grand Wailea, A Waldorf Astoria Resort! The mission of GlomCon is to provide medical education based on the best available evidence, free of commercial and ideological bias. That focus — and, since 2016, a successful track record of more than 250 live virtual seminars — revealed a natural next step: bringing the GlomCon community together for deeper learning, sharing, and networking. Our purpose-built GlomCon Hawaii 2024 conference agenda combines case presentations, pathology and treatment overviews, and lively panel discussions. This varied format helps us deliver clinical and scientific value to all attendees and ensures we continue advancing knowledge in our field. Satellite Symposium Full GlomCon Hawaii 2024 programming is available virtually and in person. A Satellite Symposium on August 6 will feature leading experts in clinical trials. Topics include: Clinical trial design Patient recruitment challenges Regulatory updates Post-market evaluation Clinical endpoints for glomerular diseases Core Conference GlomCon Hawaii 2024’s core conference continues Aug. 7–9. Areas of focus include: Aug. 7 — Renal pathologists will present in-depth, interactive lectures on the histopathology of lupus nephritis, small vessel vasculitis, podocytophathies, paraprotein-related kidney disease, and IgA nephropathy, Aug. 8–9 — A combination of lectures, case presentations, and case-based panel discussions will dissect clinicopathological correlations and evidence-based treatment approaches in all major glomerular diseases. This hybrid conference marks a much-anticipated expansion in GlomCon’s collaborative learning resources. Visit us 👇 www.glomcon.org www.pubs.glomcon.org